Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (441-450 of 488) with videos related to

Pageof 49
Sort By:
Blood|October 14, 2010
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidineRaphael Itzykson, Sylvain Thépot, Bruno Quesnel, et al.
Blood Cancer Journal|April 21, 2022
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemiaKeith W Pratz, Panayiotis Panayiotidis, Christian Recher, et al.
Blood|April 21, 2021
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA studyMatthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, et al.
Intensive Care Medicine|January 2, 2023
Clinical practice guidelines: management of severe bronchiolitis in infants under 12 months old admitted to a pediatric critical care unitChristophe Milési, Florent Baudin, Philippe Durand, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2013
Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotypeMike Recher, Marja-Liisa Karjalainen-Lindsberg, Mikael Lindlöf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2021
Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)Thomas Cluzeau, Marie Sebert, Ramy Rahmé, et al.
Nature Communications|May 26, 2021
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patientsFlorent Malard, Anne Vekhoff, Simona Lapusan, et al.
Nature Communications|February 26, 2016
A workflow to process 3D+time microscopy images of developing organisms and reconstruct their cell lineageEmmanuel Faure, Thierry Savy, Barbara Rizzi, et al.
Blood Advances|April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trialMarina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
Blood|November 1, 2011
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivoMike Recher, Lucinda J Berglund, Danielle T Avery, et al.
Pageof 49

Showing results (441-450 of 488) with videos related to

Sort By:
Pageof 49
Blood|October 14, 2010
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidineRaphael Itzykson, Sylvain Thépot, Bruno Quesnel, et al.
Blood Cancer Journal|April 21, 2022
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemiaKeith W Pratz, Panayiotis Panayiotidis, Christian Recher, et al.
Blood|April 21, 2021
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA studyMatthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, et al.
Intensive Care Medicine|January 2, 2023
Clinical practice guidelines: management of severe bronchiolitis in infants under 12 months old admitted to a pediatric critical care unitChristophe Milési, Florent Baudin, Philippe Durand, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2013
Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotypeMike Recher, Marja-Liisa Karjalainen-Lindsberg, Mikael Lindlöf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2021
Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)Thomas Cluzeau, Marie Sebert, Ramy Rahmé, et al.
Nature Communications|May 26, 2021
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patientsFlorent Malard, Anne Vekhoff, Simona Lapusan, et al.
Nature Communications|February 26, 2016
A workflow to process 3D+time microscopy images of developing organisms and reconstruct their cell lineageEmmanuel Faure, Thierry Savy, Barbara Rizzi, et al.
Blood Advances|April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trialMarina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
Blood|November 1, 2011
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivoMike Recher, Lucinda J Berglund, Danielle T Avery, et al.
Pageof 49